690 related articles for article (PubMed ID: 31602159)
1. Pathogenesis and clinical management of
de Brito BB; da Silva FAF; Soares AS; Pereira VA; Santos MLC; Sampaio MM; Neves PHM; de Melo FF
World J Gastroenterol; 2019 Oct; 25(37):5578-5589. PubMed ID: 31602159
[No Abstract] [Full Text] [Related]
2. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
[TBL] [Abstract][Full Text] [Related]
3. Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions.
Sokic-Milutinovic A; Alempijevic T; Milosavljevic T
World J Gastroenterol; 2015 Nov; 21(41):11654-72. PubMed ID: 26556993
[TBL] [Abstract][Full Text] [Related]
4. [Helicobacter pylori: virulence factors, resistance and diagnosis].
Hirschl AM; Makristathis A
Wien Med Wochenschr; 2002; 152(5-6):123-7. PubMed ID: 11998560
[TBL] [Abstract][Full Text] [Related]
5. Can eradication rate of gastric Helicobacter pylori be improved by killing oral Helicobacter pylori?
Song HY; Li Y
World J Gastroenterol; 2013 Oct; 19(39):6645-50. PubMed ID: 24151394
[TBL] [Abstract][Full Text] [Related]
6. PCR analysis and specific immunohistochemistry revealing a high prevalence of non-Helicobacter pylori Helicobacters in Helicobacter pylori-negative gastric disease patients in Japan: High susceptibility to an Hp eradication regimen.
Nakamura M; Øverby A; Michimae H; Matsui H; Takahashi S; Mabe K; Shimoyama T; Sasaki M; Terao S; Kamada T; Yanaka A; Iwamoto J; Tanabe S; Tari A; Nasu S; Suzuki H; Yamagata Murayama S
Helicobacter; 2020 Oct; 25(5):e12700. PubMed ID: 32790220
[TBL] [Abstract][Full Text] [Related]
7. Treatment of
Lahner E; Carabotti M; Annibale B
World J Gastroenterol; 2018 Jun; 24(22):2373-2380. PubMed ID: 29904244
[No Abstract] [Full Text] [Related]
8. Epidemiology, pathogenicity, risk factors, and management of
Ibrahim ME
Biomol Biomed; 2024 May; 24(3):440-453. PubMed ID: 37787623
[No Abstract] [Full Text] [Related]
9. Gut Microbiota: The Missing Link Between
Martin-Nuñez GM; Cornejo-Pareja I; Clemente-Postigo M; Tinahones FJ
Front Endocrinol (Lausanne); 2021; 12():639856. PubMed ID: 34220702
[No Abstract] [Full Text] [Related]
10. Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori.
Sugimoto M; Furuta T; Yamaoka Y
J Gastroenterol Hepatol; 2009 Nov; 24(11):1725-32. PubMed ID: 20136959
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of systemic eradication therapy against oral Helicobacter pylori.
Bago I; Bago J; Plečko V; Aurer A; Majstorović K; Budimir A
J Oral Pathol Med; 2011 May; 40(5):428-32. PubMed ID: 21198868
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
13. An Overview of Helicobacter pylori Infection.
FitzGerald R; Smith SM
Methods Mol Biol; 2021; 2283():1-14. PubMed ID: 33765303
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology and pathogenesis of Helicobacter pylori infection].
Wolle K; Leodolter A; Malfertheiner P
Wien Med Wochenschr; 2002; 152(5-6):117-22. PubMed ID: 11998559
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes.
Portal-Celhay C; Perez-Perez GI
Clin Sci (Lond); 2006 Mar; 110(3):305-14. PubMed ID: 16464172
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori: future perspectives in therapy reflecting three decades of experience.
Kanizaj TF; Kunac N
World J Gastroenterol; 2014 Jan; 20(3):699-705. PubMed ID: 24574743
[TBL] [Abstract][Full Text] [Related]
17. Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection.
Bagheri N; Shirzad H; Elahi S; Azadegan-Dehkordi F; Rahimian G; Shafigh M; Rashidii R; Sarafnejad A; Rafieian-Kopaei M; Faridani R; Tahmasbi K; Kheiri S; Razavi A
Microb Pathog; 2017 Sep; 110():165-175. PubMed ID: 28666843
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone-based protocols for eradication of Helicobacter pylori.
Rispo A; Capone P; Castiglione F; Pasquale L; Rea M; Caporaso N
World J Gastroenterol; 2014 Jul; 20(27):8947-56. PubMed ID: 25083067
[TBL] [Abstract][Full Text] [Related]
19. Medicinal plant activity on Helicobacter pylori related diseases.
Wang YC
World J Gastroenterol; 2014 Aug; 20(30):10368-82. PubMed ID: 25132753
[TBL] [Abstract][Full Text] [Related]
20. Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.
Testerman TL; Morris J
World J Gastroenterol; 2014 Sep; 20(36):12781-808. PubMed ID: 25278678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
